NTF Presentations for RNTCP Sensitization First edition 10 th Nov 06 Presentation 1 Introduction Contents Global Tuberculosis Scenario Burden of Tuberculosis.

Slides:



Advertisements
Similar presentations
Stop TB Strategy Planning Frameworks Mukund Uplekar TB Strategy, Operations and Health Systems, Stop TB Department, WHO.
Advertisements

Improving diagnosis TB laboratory strengthening.
Breaking Silos: TB and Poverty Bobby Ramakant, Rachael Thomson STOP TB Partnership TB and Poverty Subgroup.
ARIAtlas.org. Global Impact TB causes nearly two million deaths a year, making it the world’s seventh most common cause of mortality. More than two billion.
Introduction India has the highest burden of tuberculosis in the world, with an estimated 2 million cases annually, accounting for 1/5 th of global incidence.
Status of RNTCP in Gujarat
Monitoring and Evaluation: Tuberculosis Control Programs
Compendium of Indicators for Monitoring and Evaluating National Tuberculosis Programs.
Technical Advisory Group meeting, WHO/WPRO
National Tuberculosis Control Program
Monitoring & Evaluation of RNTCP
Revised National Tuberculosis Control Programme (RNTCP)
Status of Revised National Tuberculosis Control Program (RNTCP) in India Dr Jitendra.
Pakistan.
1 Global and Regional Tuberculosis (TB) update ACSM workshop, Amman, Jordan April 13-17, 2008 Dr. Sevil Huseynova.
MDR-TB: a fight we cannot afford to lose! Alexander Golubkov, MD, MPH Senior TB Technical Advisor.
TB 101: TB Basics and Global Approaches. Objectives Review basic TB facts. Define common TB terms. Describe key global TB prevention and care strategies.
THE FIGHT TO STOP TB WHAT ARE WE FIGHTING? TUBERCULOSIS: THE WORLD’S NO. 1 KILLER AMONG CURABLE, INFECTIOUS DISEASES But there is hope PEOPLE WHO HAVE.
DTOs Quarterly Review Meeting, Ahmedabad 25th Oct 2013
Framework and Standards for Effective TB Control Module 3 – March 2010
DRUG-RESISTANT TB in SOUTH AFRICA: Issues & Response _ ______ _____ _ ______ _____ ___ __ __ __ __ __ _______ ___ ________ ___ _______ _________ __ _____.
Combat HIV-AIDS, malaria & other diseases Goal 6..
Unit 1: Overview of HIV/AIDS Case Reporting #6-0-1.
DEPARTMENT OF HEALTH DOTS Program for TB (Tuberculosis Directly Observed Short-course)
Monitoring and Evaluation Module 12 – March 2010.
The Research and Development Goals of the Global Plan to Stop TB Marcos Espinal Executive Secretary.
TB and Poverty in The Global Plan to Stop TB Valerie Diaz, Sarah England, Knut Lönnroth, Giorgio Roscigno Stop TB Partnership Stop TB Department,
Our vision: Healthier communities, Excellence in healthcare Our values: Teamwork, Honesty, Respect, Ethical, Excellence, Caring, Commitment, Courage DOTS.
World TB Day 2000 Forging New Partnerships to Stop TB Produced by the [ Stop TB Initiative ] Coordinating Team: WHO.
Project Goals  Support the National Tb Program (NTP)  Developed National Guidelines for prevention and control of Tb  Developed guidelines for treating.
African Business Leaders on Health: GBC Conference on TB, HIV-TB Co-infection & Global Fund Partnership Johannesburg, October 11, 2010 The state of Global.
Sanghyuk Shin, PhD Department of Epidemiology UCLA Fielding School of Public Health Aug 27, 2015 Tuberculosis and HIV Co-infection: “A Deadly Syndemic”
B.L.TEJASWI INTERN JJMMC. Which is the biggest disease today ?????
NATIONAL TB 2012 INDICATOR ANALYSIS REPORT Presented by: Sandile Ginindza Lugogo Sun Hotel 05 th -7 th June 2013 Ministry of Health NTCP.
1 [INSERT SPEAKER NAME DATE & LOCATION HERE] Ethics of Tuberculosis Prevention, Care and Control MODULE 2: BACKGROUND ON TUBERCULOSIS Insert country/ministry.
Proposed Post-2015 Global Tuberculosis Strategy and Targets Dr Mario Raviglione Director, Global TB Programme World Health Organization, Geneva, Switzerland.
Health Organization The Challenges Facing Tuberculosis Control Blantyre Hospital, Malawi: TB Division, 3 patients per bed.
Tuberculosis control in Suriname Situational analysis.
Millennium Development Goals Presenter: Dr. K Sushma Moderator: Dr. S. S.Gupta.
PERSPECTIVES FROM THE FIELD DR LYDIA MUNGHERERA TASO (The Aids Support Organisation) UGANDA REVERSING THE TIDE OF TB.
Country Office for Bangladesh Towards reaching the Millennium Development Goals Dr Erwin Cooreman Medical Officer (TB) WHO-Bangladesh.
National Tuberculosis Control Program in Bangladesh : Progress Report Dr. Shamim Sultana Deputy Programme Manager, TB National TB Control Programme.
Contribution of operational research in China National Center for TB Control and Prevention, China CDC Jiang Shiwen Cancun.
American Public Health Association – Annual Meeting 2007 Politics, Policy and Public Health Session : Institutionalizing Tuberculosis Control Strengthening.
Outline of Current Situation Survey on HIV/AIDS (Proposal) Ms. Keiko Dozono Director for AIDS and Emerging Infectious Disease Control Health and Safety.
Revised National Tuberculosis Control Programme Update and Challenges Dr. B Mahadev, CMO National Tuberculosis Institute Bangalore ZTF (South Zone) Workshop,
Compendium of Indicators for Monitoring and Evaluating National Tuberculosis Programs.
Welcome And Namaste. “His Majesty's Government of Nepal has embraced the sprit of the Millennium Declaration and is committed to the achievement of the.
Stop TB in China Challenges, Constraints & Actions Dr Wang Longde Vice Minister of Health China 24 March 2004.
TB AND HIV: “THE STRATEGIC VISION FOR THE COUNTRY” Dr Lindiwe Mvusi 18 May 2012 MMPA Congress 2012.
Taipei, June Content  Introduction about Vietnam’s Programmatic Management of Drug resistant Tuberculosis (PMDT) and drug resistant tuberculosis.
Dr. Somil Nagpal, ICAS MBBS, MHA, MBA, F. I. I. I
Dr. L.S. Chauhan Deputy Director General (TB) Central TB Division
TB- HIV Collaborative activities in Romania- may 2006 status
Summary of changes in the RNTCP technical guidelines in
Prisons and TB in Europe
TB/HIV surveillance : Who is going to get the job done?
Monitoring the implementation of the TB Action Plan for the WHO European Region, 2016–2020 EU/EEA situation in 2016 ECDC Tuberculosis Programme European.
Presentation 1 Introduction
Knowledge gaps in formulating TB Control Policies for Prisons
Key issues in DOTS implementation
The role of the community in TB control
Indian Scenario HIV Situation TB Situation
Vietnam Investment and Finance for TB
monitoring & evaluation THD Unit, Stop TB department WHO Geneva
The Global Fund to Fight AIDS, Tuberculosis and Malaria
South Africa: From ProTest to Nationwide Implementation
From ProTEST to Nationwide Implementation
The STOP TB Strategy – 2009 VISION: A TB-free world
33rd IUATLD World Conference on Lung Health
Presentation transcript:

NTF Presentations for RNTCP Sensitization First edition 10 th Nov 06 Presentation 1 Introduction Contents Global Tuberculosis Scenario Burden of Tuberculosis in India RNTCP- Evolution, objectives, structure, achievements

NTF Presentations for RNTCP Sensitization First edition 10 th Nov 06 Global burden of TB 2 billion infected, i.e. 1 in 3 of global population 9.4 million (139/lakh) new cases in 2008, 80% in 22 high-burden countries 4 m new sm+ve PTB (61/lakh) cases in 2008 Global incidence of TB has peaked in 2004 and is declining. 1.77m deaths in 2007, 98% in low-income countries MDR-TB -prevalence in new cases around 3.6% Ref: WHO Global Report, 2006

Estimated TB incidence rate, 2007 : Source: WHO Geneva; WHO Report 2009: Global Tuberculosis Control; Surveillance, Planning and Financing

NTF Presentations for RNTCP Sensitization First edition 10 th Nov 06 Millennium Development Goals Goal 6: “Combat HIV/AIDS, malaria and other diseases” –Target 8: “By 2015, to have halted and begun to reverse the incidence of malaria and other major diseases…” Indicator 23: between 1990 and 2015 to halve prevalence of TB disease and deaths due to TB Indicator 24: to detect 70% of new infectious cases and to successfully treat 85% of detected sputum positive patients

NTF Presentations for RNTCP Sensitization First edition 10 th Nov 06 Stop TB Partnership Targets By 2005: –At least 70% people with sputum smear positive TB will be diagnosed. –At least 85% cured. By 2015: –Global burden of TB (prevalence and death rates) will be reduced by 50% relative to 1990 levels. Reduce prevalence to <150 per lakh population Reduce deaths to <15 per lakh population –Number of people dying from TB in 2015 should be less than 1 million, including those co-infected with HIV By 2050: –Global incidence of TB disease will be less than or equal to 1 case per million population per year

NTF Presentations for RNTCP Sensitization First edition 10 th Nov 06 Stop TB Strategy, 2006 Vision: A world free of TB Goal: To dramatically reduce the global burden of TB by 2015 in line with Millennium Development Goals and the Stop TB Partnership targets

NTF Presentations for RNTCP Sensitization First edition 10 th Nov 06 Components of Stop TB Strategy, Pursuing high-quality DOTS expansion and enhancement 2.Addressing TB/HIV, MDR-TB and other challenges 3.Contributing to health system strengthening 4.Engaging all health providers 5.Empowering people with TB, and communities 6.Enabling and promoting research

NTF Presentations for RNTCP Sensitization First edition 10 th Nov Government commitment to TB control 2. Diagnosis by smear microscopy mostly on self- reporting symptomatic patients 3. Standardised short course chemotherapy (SCC) with direct observation of treatment (DOT) 4. Efficient system of drug supply 5. Efficient recording and reporting system with assessment of treatment results Five components were expanded in 2002 Directly Observed Treatment, Short-course strategy (DOTS), 1994

NTF Presentations for RNTCP Sensitization First edition 10 th Nov 06 Global Situation Since 1995,over 21 million patients have been diagnosed and treated in DOTS programmes In 2007, 5.5 million new and relapse TB cases were initiated on treatment under DOTS strategy Of 2.5 million new smear positive patients registered in 2006, 85% were successfully treated under DOTS

NTF Presentations for RNTCP Sensitization First edition 10 th Nov 06

International Standards for TB Care-2006-revised in 2009 Developed by Tuberculosis Coalition for Technical Assistance Members of TCTA –American Thoracic Society –WHO (World Health Organisation) –CDC (Center for Disease Control and Prevention) – KCNV(Dutch Tuberculosis Foundation), –IUATLD (The International Union Against Tuberculosis and Lung Disease) Part of the new STOP TB Strategy and global plan to Stop TB

NTF Presentations for RNTCP Sensitization First edition 10 th Nov 06 International Standards for TB Care The ISTC is designed to address the care of patients of all ages with any manifestation of the disease, including multi-drug resistant and extra- pulmonary tuberculosis and tuberculosis combined with HIV infection. The ISTC is also designed to guide providers everywhere, regardless of the circumstances of their practice. Consists of 21 standards for Public Health Responsibility

NTF Presentations for RNTCP Sensitization First edition 10 th Nov 06 INDIA

NTF Presentations for RNTCP Sensitization First edition 10 th Nov 06 Problem of TB in India Estimated incidence –1.96 million new cases annually –0.8 million new smear positive cases annually –75 new smear positive PTB cases/1lakh population per year Estimated prevalence of TB disease –3.8 million bacillary cases in 2000 –1.7 million new smear positive cases in 2000 Estimated mortality –330,000 deaths due to TB each year –Over 1000 deaths a day –2 deaths every 3 minutes Gopi P et al (TRC), IJMR, Sep 2005

NTF Presentations for RNTCP Sensitization First edition 10 th Nov 06 Problem of TB in India (contd) Prevalence of TB infection –40% (~400m) infected with M. tuberculosis (with a 10% lifetime risk of TB disease in the absence of HIV) Estimated Multi-drug resistant TB –< 3% in new cases –12% in re-treatment cases TB-HIV –~ 2.31 million people living with HIV (PLWHA) –10-15% annual risk (60% lifetime risk) of developing active TB disease in PLWHA –Estimated ~ 5% of TB patients are HIV infected

NTF Presentations for RNTCP Sensitization First edition 10 th Nov 06 India is the highest TB burden country accounting for more than one-fifth of the global incidence Source: WHO Geneva; WHO Report 2009: Global Tuberculosis Control; Surveillance, Planning and Financing Global annual incidence = 9.4 million India annual incidence = 1.96 million India is 17 th among 22 High Burden Countries (in terms of TB incidence rate)

NTF Presentations for RNTCP Sensitization First edition 10 th Nov 06 Estimated Incidence of TB in India* (No. of NSP Cases per 100,000 population, per year) National75 North Zone95 East Zone75** West Zone80 South Zone75** North West East South * Estimated from recent ARTI survey ** For programme monitoring purpose estimated cases in East & South zones have been kept at the national level of 75 and this is within the upper limit of CI or ARTI in these zones Source: Module 9, Managing the RNTCP in your area

NTF Presentations for RNTCP Sensitization First edition 10 th Nov 06 Social and Economic Burden of TB in India Estimated burden per year Indirect costs to society $3 billion Direct costs to society $300 million Productive work days lost due to TB illness 100 million Productive work days lost due to TB deaths1.3 billion School drop-outs due to parental TB300,000 Women rejected by families due to TB100,000 TRC, Socio-economic impact of TB on patients and family in India, Int J Tub Lung Dis :

NTF Presentations for RNTCP Sensitization First edition 10 th Nov 06 RNTCP

NTF Presentations for RNTCP Sensitization First edition 10 th Nov 06 Evolution of TB Control in India 1950s-60s Important TB research at TRC and NTI 1962 National TB Programme (NTP) 1992 Programme Review only 30% of patients diagnosed; of these, only 30% treated successfully 1993 RNTCP pilot began 1998 RNTCP scale-up million population covered 2004 >80% of country covered 2006Entire country covered by RNTCP

NTF Presentations for RNTCP Sensitization First edition 10 th Nov 06 Objectives of RNTCP To achieve and maintain a cure rate of at least 85% among newly detected infectious (new sputum smear positive) cases To achieve and maintain detection of at least 70% of such cases in the population

NTF Presentations for RNTCP Sensitization First edition 10 th Nov 06 RNTCP Organization structure: State level Health Minister Health Secretary MD NRHM Director Health Services Additional / Deputy / Joint Director (State TB Officer) Organizational Chart Ministry of Health and Family Welfare Directorate General of Health Services Central TB Division State TB Cell Deputy STO, MO, Accountant, IEC Officer, SA, DEO, TB HIV Coordinator etc., State Training and Demonstration Center (TB) Director, IRL Microbiologist, MO, Epidemiologist/statistician, IRL LTs etc.,

NTF Presentations for RNTCP Sensitization First edition 10 th Nov 06 One/ 100,000 (50,000 in hilly/ difficult/ tribal area) One/ 500,000 (250,000 in hilly/ difficult/ tribal area) TB Health Visitors (TBHV), DOT Provider (MPW, NGO, PP, ASHA, Community Volunteers) Medical Officer, paramedical staff And Laboratory Technician (20-50%) Medical officer-TB Control, Senior Treatment supervisor(STS), Senior TB Laboratory Supervisor(STLS) District Health Services District TB Centre Tuberculosis Unit Microscopy Centre DOT Centre Nodal point for TB control Structure of RNTCP at district levels Chief Medical Officer and other supporting staff District Administration District Magistrate/ District Collector DTO, MO-DTC (15%), LT, DEO, Driver, Urban TB Coordinators, TBHVs, Communication Facilitators

NTF Presentations for RNTCP Sensitization First edition 10 th Nov 06 Unique features of RNTCP District TB Control Society Modular training Patient wise boxes Sub-district level supervisory staff (STS, STLS) for treatment & microscopy Robust reporting and recording system

NTF Presentations for RNTCP Sensitization First edition 10 th Nov 06 Population projected from 2001 census Estimated no. of NSP cases - 75/100,000 population per year (based on recent ARTI report) Annualized New Smear-Positive Case Detection Rate and Treatment Success Rate in DOTS Areas, India, *

NTF Presentations for RNTCP Sensitization First edition 10 th Nov 06 Impact of RNTCP Cure rate more than doubled compared with earlier NTP, 85% global target consistently achieved 2003 onwards Case detection rate is more than 70% Case fatality reduced from 29% to 4% in NSP cases, and deaths due to TB from 500,000 to <330,000 a year Over 11 million patients initiated on DOTS, and over 2 million additional lives saved